Bermuda | 98-014-1974 |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification Number) |
Page | ||
ITEM 1. | ||
ITEM 2. | ||
ITEM 3. | ||
ITEM 4. | ||
ITEM 1. | ||
ITEM 1A. | ||
ITEM 2. | ||
ITEM 3. | ||
ITEM 4. | ||
ITEM 5. | ||
ITEM 6. | ||
September 30, 2013 | December 31, 2012 | ||||||
Assets | (Unaudited) | (Audited) | |||||
Fixed maturity investments trading, at fair value | |||||||
(Amortized cost $4,722,167 and $4,549,112 at September 30, 2013 and December 31, 2012, respectively) | $ | 4,751,237 | $ | 4,660,168 | |||
Fixed maturity investments available for sale, at fair value | |||||||
(Amortized cost $34,091 and $71,445 at September 30, 2013 and December 31, 2012, respectively) | 38,530 | 83,442 | |||||
Short term investments, at fair value | 925,329 | 821,163 | |||||
Equity investments trading, at fair value | 113,986 | 58,186 | |||||
Other investments, at fair value | 500,770 | 644,711 | |||||
Investments in other ventures, under equity method | 97,660 | 87,724 | |||||
Total investments | 6,427,512 | 6,355,394 | |||||
Cash and cash equivalents | 266,350 | 304,145 | |||||
Premiums receivable | 735,937 | 491,365 | |||||
Prepaid reinsurance premiums | 166,340 | 77,082 | |||||
Reinsurance recoverable | 149,201 | 192,512 | |||||
Accrued investment income | 26,887 | 33,478 | |||||
Deferred acquisition costs | 103,844 | 52,622 | |||||
Receivable for investments sold | 240,191 | 168,673 | |||||
Other assets | 113,159 | 110,777 | |||||
Goodwill and other intangible assets | 8,978 | 8,486 | |||||
Assets of discontinued operations held for sale | 115,556 | 134,094 | |||||
Total assets | $ | 8,353,955 | $ | 7,928,628 | |||
Liabilities, Noncontrolling Interests and Shareholders’ Equity | |||||||
Liabilities | |||||||
Reserve for claims and claim expenses | $ | 1,683,709 | $ | 1,879,377 | |||
Unearned premiums | 754,077 | 399,517 | |||||
Debt | 249,407 | 349,339 | |||||
Reinsurance balances payable | 358,988 | 290,419 | |||||
Payable for investments purchased | 407,788 | 278,787 | |||||
Other liabilities | 183,362 | 198,434 | |||||
Liabilities of discontinued operations held for sale | 56,275 | 57,440 | |||||
Total liabilities | 3,693,606 | 3,453,313 | |||||
Commitments and Contingencies | |||||||
Redeemable noncontrolling interest | 945,915 | 968,259 | |||||
Shareholders’ Equity | |||||||
Preference Shares: $1.00 par value – 16,000,000 shares issued and outstanding at September 30, 2013 (December 31, 2012 – 16,000,000) | 400,000 | 400,000 | |||||
Common shares: $1.00 par value – 44,390,632 shares issued and outstanding at September 30, 2013 (December 31, 2012 – 45,542,203) | 44,391 | 45,542 | |||||
Accumulated other comprehensive income | 4,566 | 13,622 | |||||
Retained earnings | 3,261,757 | 3,043,901 | |||||
Total shareholders’ equity attributable to RenaissanceRe | 3,710,714 | 3,503,065 | |||||
Noncontrolling interest | 3,720 | 3,991 | |||||
Total shareholders’ equity | 3,714,434 | 3,507,056 | |||||
Total liabilities, noncontrolling interests and shareholders’ equity | $ | 8,353,955 | $ | 7,928,628 |
Three months ended | Nine months ended | ||||||||||||||
September 30, 2013 | September 30, 2012 | September 30, 2013 | September 30, 2012 | ||||||||||||
Revenues | |||||||||||||||
Gross premiums written | $ | 182,649 | $ | 136,359 | $ | 1,521,290 | $ | 1,467,846 | |||||||
Net premiums written | $ | 127,241 | $ | 105,035 | $ | 1,123,163 | $ | 1,025,240 | |||||||
Decrease (increase) in unearned premiums | 167,476 | 157,588 | (265,302 | ) | (239,536 | ) | |||||||||
Net premiums earned | 294,717 | 262,623 | 857,861 | 785,704 | |||||||||||
Net investment income | 59,931 | 46,135 | 129,296 | 126,725 | |||||||||||
Net foreign exchange gains | 488 | 3,187 | 170 | 3,468 | |||||||||||
Equity in earnings of other ventures | 7,313 | 4,310 | 16,920 | 16,626 | |||||||||||
Other income (loss) | 651 | (1,053 | ) | (2,186 | ) | 730 | |||||||||
Net realized and unrealized gains (losses) on investments | 28,472 | 75,297 | (26,788 | ) | 150,982 | ||||||||||
Total other-than-temporary impairments | — | — | — | (395 | ) | ||||||||||
Portion recognized in other comprehensive income, before taxes | — | — | — | 52 | |||||||||||
Net other-than-temporary impairments | — | — | — | (343 | ) | ||||||||||
Total revenues | 391,572 | 390,499 | 975,273 | 1,083,892 | |||||||||||
Expenses | |||||||||||||||
Net claims and claim expenses incurred | 60,928 | 73,215 | 192,141 | 138,318 | |||||||||||
Acquisition expenses | 37,699 | 24,438 | 94,475 | 74,157 | |||||||||||
Operational expenses | 44,672 | 42,356 | 133,447 | 126,055 | |||||||||||
Corporate expenses | 4,307 | 3,796 | 30,318 | 12,567 | |||||||||||
Interest expense | 4,298 | 5,891 | 13,632 | 17,325 | |||||||||||
Total expenses | 151,904 | 149,696 | 464,013 | 368,422 | |||||||||||
Income from continuing operations before taxes | 239,668 | 240,803 | 511,260 | 715,470 | |||||||||||
Income tax expense | (223 | ) | (144 | ) | (356 | ) | (1,008 | ) | |||||||
Income from continuing operations | 239,445 | 240,659 | 510,904 | 714,462 | |||||||||||
(Loss) income from discontinued operations | (9,779 | ) | (166 | ) | 2,422 | (25,505 | ) | ||||||||
Net income | 229,666 | 240,493 | 513,326 | 688,957 | |||||||||||
Net income attributable to noncontrolling interests | (44,331 | ) | (51,083 | ) | (96,953 | ) | (138,348 | ) | |||||||
Net income attributable to RenaissanceRe | 185,335 | 189,410 | 416,373 | 550,609 | |||||||||||
Dividends on preference shares | (5,595 | ) | (8,750 | ) | (19,353 | ) | (26,250 | ) | |||||||
Net income available to RenaissanceRe common shareholders | $ | 179,740 | $ | 180,660 | $ | 397,020 | $ | 524,359 | |||||||
Income from continuing operations available to RenaissanceRe common shareholders per common share – basic | $ | 4.32 | $ | 3.67 | $ | 8.95 | $ | 10.89 | |||||||
(Loss) income from discontinued operations available to RenaissanceRe common shareholders per common share – basic | (0.23 | ) | — | 0.06 | (0.51 | ) | |||||||||
Net income available to RenaissanceRe common shareholders per common share – basic | $ | 4.09 | $ | 3.67 | $ | 9.01 | $ | 10.38 | |||||||
Income from continuing operations available to RenaissanceRe common shareholders per common share – diluted | $ | 4.23 | $ | 3.62 | $ | 8.79 | $ | 10.75 | |||||||
(Loss) income from discontinued operations available to RenaissanceRe common shareholders per common share – diluted | (0.22 | ) | — | 0.05 | (0.51 | ) | |||||||||
Net income available to RenaissanceRe common shareholders per common share – diluted | $ | 4.01 | $ | 3.62 | $ | 8.84 | $ | 10.24 | |||||||
Dividends per common share | $ | 0.28 | $ | 0.27 | $ | 0.84 | $ | 0.81 |
Three months ended | Nine months ended | ||||||||||||||
September 30, 2013 | September 30, 2012 | September 30, 2013 | September 30, 2012 | ||||||||||||
Comprehensive income | |||||||||||||||
Net income | $ | 229,666 | $ | 240,493 | $ | 513,326 | $ | 688,957 | |||||||
Change in net unrealized gains on investments | (343 | ) | 1,536 | (9,056 | ) | 2,359 | |||||||||
Portion of other-than-temporary impairments recognized in other comprehensive income | — | — | — | (52 | ) | ||||||||||
Comprehensive income | 229,323 | 242,029 | 504,270 | 691,264 | |||||||||||
Net income attributable to noncontrolling interests | (44,331 | ) | (51,083 | ) | (96,953 | ) | (138,348 | ) | |||||||
Comprehensive income attributable to noncontrolling interests | (44,331 | ) | (51,083 | ) | (96,953 | ) | (138,348 | ) | |||||||
Comprehensive income attributable to RenaissanceRe | $ | 184,992 | $ | 190,946 | $ | 407,317 | $ | 552,916 | |||||||
Disclosure regarding net unrealized gains | |||||||||||||||
Total realized and net unrealized holding gains (losses) on investments and net other-than-temporary impairments | $ | 25 | $ | 2,293 | $ | (1,508 | ) | $ | 4,822 | ||||||
Net realized gains on fixed maturity investments available for sale | (368 | ) | (757 | ) | (7,548 | ) | (2,806 | ) | |||||||
Net other-than-temporary impairments recognized in earnings | — | — | — | 343 | |||||||||||
Change in net unrealized gains on investments | $ | (343 | ) | $ | 1,536 | $ | (9,056 | ) | $ | 2,359 |
Nine months ended | |||||||
September 30, 2013 | September 30, 2012 | ||||||
Preference shares | |||||||
Balance – January 1 | $ | 400,000 | $ | 550,000 | |||
Issuance of shares | 275,000 | — | |||||
Repurchase of shares | (275,000 | ) | — | ||||
Balance – September 30 | 400,000 | 550,000 | |||||
Common shares | |||||||
Balance – January 1 | 45,542 | 51,543 | |||||
Repurchase of shares | (1,722 | ) | (3,619 | ) | |||
Exercise of options and issuance of restricted stock awards | 571 | 304 | |||||
Balance – September 30 | 44,391 | 48,228 | |||||
Additional paid-in capital | |||||||
Balance – January 1 | — | — | |||||
Repurchase of shares | 3,019 | (19,423 | ) | ||||
Offering expenses | (9,345 | ) | — | ||||
Change in noncontrolling interests | 622 | 7,176 | |||||
Exercise of options and issuance of restricted stock awards | 5,704 | 12,247 | |||||
Balance – September 30 | — | — | |||||
Accumulated other comprehensive income | |||||||
Balance – January 1 | 13,622 | 11,760 | |||||
Change in net unrealized gains on investments | (9,056 | ) | 2,359 | ||||
Portion of other-than-temporary impairments recognized in other comprehensive income | — | (52 | ) | ||||
Balance – September 30 | 4,566 | 14,067 | |||||
Retained earnings | |||||||
Balance – January 1 | 3,043,901 | 2,991,890 | |||||
Net income | 513,326 | 688,957 | |||||
Net income attributable to noncontrolling interests | (96,953 | ) | (138,348 | ) | |||
Repurchase of shares | (142,208 | ) | (248,847 | ) | |||
Dividends on common shares | (36,956 | ) | (40,741 | ) | |||
Dividends on preference shares | (19,353 | ) | (26,250 | ) | |||
Balance – September 30 | 3,261,757 | 3,226,661 | |||||
Noncontrolling interest | 3,720 | 3,979 | |||||
Total shareholders’ equity | $ | 3,714,434 | $ | 3,842,935 |
Nine months ended | |||||||
September 30, 2013 | September 30, 2012 | ||||||
Cash flows provided by operating activities | |||||||
Net income | $ | 513,326 | $ | 688,957 | |||
Adjustments to reconcile net income to net cash provided by operating activities | |||||||
Amortization, accretion and depreciation | 42,423 | 45,303 | |||||
Equity in undistributed earnings of other ventures | (12,048 | ) | (12,309 | ) | |||
Net realized and unrealized losses (gains) on investments | 26,806 | (150,984 | ) | ||||
Net other-than-temporary impairments | — | 343 | |||||
Net unrealized gains included in net investment income | (33,836 | ) | (35,963 | ) | |||
Net unrealized losses included in other income (loss) | 12,782 | 10,713 | |||||
Change in: | |||||||
Premiums receivable | (244,572 | ) | (229,362 | ) | |||
Prepaid reinsurance premiums | (89,258 | ) | (131,070 | ) | |||
Reinsurance recoverable | 43,311 | 194,539 | |||||
Deferred acquisition costs | (51,222 | ) | (39,501 | ) | |||
Reserve for claims and claim expenses | (195,668 | ) | (209,674 | ) | |||
Unearned premiums | 354,560 | 370,606 | |||||
Reinsurance balances payable | 68,569 | 99,253 | |||||
Other | (49,375 | ) | (65,185 | ) | |||
Net cash provided by operating activities | 385,798 | 535,666 | |||||
Cash flows used in investing activities | |||||||
Proceeds from sales and maturities of fixed maturity investments trading | 6,356,691 | 6,287,723 | |||||
Purchases of fixed maturity investments trading | (6,449,697 | ) | (6,886,239 | ) | |||
Proceeds from sales and maturities of fixed maturity investments available for sale | 43,564 | 47,925 | |||||
Net purchases of equity investments trading | (33,714 | ) | — | ||||
Net (purchases) sales of short term investments | (118,126 | ) | 170,162 | ||||
Net sales of other investments | 198,101 | 41,262 | |||||
Net purchases of investments in other ventures | (2,500 | ) | — | ||||
Net purchases of other assets | (994 | ) | (4,204 | ) | |||
Net cash used in investing activities | (6,675 | ) | (343,371 | ) | |||
Cash flows used in financing activities | |||||||
Dividends paid – RenaissanceRe common shares | (36,956 | ) | (40,741 | ) | |||
Dividends paid – preference shares | (19,353 | ) | (26,250 | ) | |||
RenaissanceRe common share repurchases | (140,911 | ) | (257,461 | ) | |||
Net repayment of debt | (100,847 | ) | 4,907 | ||||
Redemption of 6.08% Series C preference shares | (125,000 | ) | — | ||||
Redemption of 6.60% Series D preference shares | (150,000 | ) | — | ||||
Issuance of 5.375% Series E preference shares, net of expenses | 265,655 | — | |||||
Net third party DaVinciRe share transactions | (116,628 | ) | 157,999 | ||||
Third party investment in redeemable noncontrolling interest | 13,000 | — | |||||
Net cash used in financing activities | (411,040 | ) | (161,546 | ) | |||
Effect of exchange rate changes on foreign currency cash | 3,366 | 1,390 | |||||
Net (decrease) increase in cash and cash equivalents | (28,551 | ) | 32,139 | ||||
Net (increase) decrease in cash and cash equivalents of discontinued operations | (9,244 | ) | 12,169 | ||||
Cash and cash equivalents, beginning of period | 304,145 | 181,825 | |||||
Cash and cash equivalents, end of period | $ | 266,350 | $ | 226,133 |
• | Renaissance Reinsurance Ltd. (“Renaissance Reinsurance”), the Company’s principal reinsurance subsidiary, provides property catastrophe and specialty reinsurance coverages to insurers and reinsurers on a worldwide basis. |
• | The Company also manages property catastrophe and specialty reinsurance business written on behalf of joint ventures, which principally include Top Layer Reinsurance Ltd. (“Top Layer Re”), recorded under the equity method of accounting, and DaVinci Reinsurance Ltd. (“DaVinci”). Because the Company owns a noncontrolling equity interest in, but controls a majority of the outstanding voting power of DaVinci's parent, DaVinciRe Holdings Ltd. (“DaVinciRe”), the results of DaVinci and DaVinciRe are consolidated in the Company’s financial statements. Redeemable noncontrolling interest – DaVinciRe represents the interests of external parties with respect to the net income and shareholders’ equity of DaVinciRe. Renaissance Underwriting Managers, Ltd. (“RUM”), a wholly owned subsidiary, acts as exclusive underwriting manager for these joint ventures in return for fee-based income and profit participation. |
• | RenaissanceRe Syndicate 1458 (“Syndicate 1458”) is the Company’s Lloyd’s syndicate. RenaissanceRe Corporate Capital (UK) Limited (“RenaissanceRe CCL”), a wholly owned subsidiary of RenaissanceRe, is Syndicate 1458’s sole corporate member and RenaissanceRe Syndicate Management Ltd. (“RSML”), a wholly owned subsidiary of RenaissanceRe, is the managing agent for Syndicate 1458. |
• | RenaissanceRe Specialty Risks Ltd., formerly known as Glencoe Insurance Ltd. (“RenaissanceRe Specialty Risks”), is a Bermuda-domiciled excess and surplus lines insurance company that is currently eligible to do business on an excess and surplus lines basis in 49 U.S. states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. RenaissanceRe Underwriting Managers U.S. LLC, a specialty reinsurance agency domiciled in Connecticut, provides specialty treaty reinsurance solutions on both a quota share and excess of loss basis; and writes business on behalf of RenaissanceRe Specialty U.S. Ltd. ("RenaissanceRe Specialty U.S."), a Bermuda-domiciled reinsurer launched in June 2013 which operates subject to U.S. federal income tax, and RenaissanceRe Syndicate 1458. |
• | On August 30, 2013, the Company entered into a purchase agreement with a subsidiary of Munich-American Holding Corporation (together with applicable affiliates, "Munich") to sell its U.S.-based weather and weather-related energy risk management unit, which principally included RenRe Commodity Advisors LLC ("RRCA"), Renaissance Trading Ltd. ("Renaissance Trading") and RenRe Energy Advisors Ltd. (collectively referred to as "REAL"). REAL offered certain derivative-based risk management products primarily to address weather and energy risk and engaged in hedging and trading activities related to those transactions. On October 1, 2013, the Company closed the sale of REAL to Munich. The Company has classified the assets and liabilities associated with this transaction as held for sale. The financial results for these operations have been presented in the Company’s consolidated financial statements as “discontinued operations” for all periods presented. Refer to “Note 3. Discontinued Operations”, for more information. |
September 30, 2013 | December 31, 2012 | ||||||
Assets of discontinued operations held for sale | |||||||
Fixed maturity investments trading, at fair value | |||||||
(Amortized cost $Nil and $5,250 at September 30, 2013 and December 31, 2012, respectively) | $ | — | $ | 5,253 | |||
Cash and cash equivalents | 30,457 | 21,213 | |||||
Other assets | 85,099 | 107,628 | |||||
Total assets of discontinued operations held for sale | $ | 115,556 | $ | 134,094 | |||
Liabilities of discontinued operations held for sale | |||||||
Debt | $ | 1,589 | $ | 2,436 | |||
Other liabilities | 54,686 | 55,004 | |||||
Total liabilities of discontinued operations held for sale | 56,275 | 57,440 | |||||
Shareholder's equity of discontinued operations held for sale | |||||||
Total shareholder's equity of discontinued operations held for sale | 59,281 | 76,654 | |||||
Total liabilities and shareholder's equity of discontinued operations held for sale | $ | 115,556 | $ | 134,094 |
Three months ended | Nine months ended | ||||||||||||||
September 30, 2013 | September 30, 2012 | September 30, 2013 | September 30, 2012 | ||||||||||||
Revenues | |||||||||||||||
Net investment (loss) income | $ | (3 | ) | $ | (16 | ) | $ | 1,150 | $ | 2,543 | |||||
Net foreign exchange (losses) gains | (140 | ) | (186 | ) | 849 | 483 | |||||||||
Other (loss) income | (1,001 | ) | 171 | 9,471 | (29,416 | ) | |||||||||
Net realized and unrealized (losses) gains on investments | (5 | ) | 6 | (18 | ) | 2 | |||||||||
Total revenues | (1,149 | ) | (25 | ) | 11,452 | (26,388 | ) | ||||||||
Expenses | |||||||||||||||
Operational expenses | 30 | 33 | 89 | 125 | |||||||||||
Corporate expenses | (2 | ) | 54 | 104 | 161 | ||||||||||
Total expenses | 28 | 87 | 193 | 286 | |||||||||||
(Loss) income before taxes | (1,177 | ) | (112 | ) | 11,259 | (26,674 | ) | ||||||||
Income tax benefit (expense) | 168 | — | (67 | ) | 3 | ||||||||||
(Loss) income from discontinued operations related to REAL | $ | (1,009 | ) | $ | (112 | ) | $ | 11,192 | $ | (26,671 | ) | ||||
Loss on sale of REAL | (8,770 | ) | — | (8,770 | ) | — | |||||||||
(Loss) income from discontinued operations related to the former U.S.-based insurance operations | $ | — | $ | (54 | ) | $ | — | $ | 1,166 | ||||||
(Loss) income from discontinued operations | $ | (9,779 | ) | $ | (166 | ) | $ | 2,422 | $ | (25,505 | ) |
September 30, 2013 | December 31, 2012 | ||||||||
U.S. treasuries | $ | 1,322,367 | $ | 1,254,547 | |||||
Agencies | 197,047 | 315,154 | |||||||
Non-U.S. government (Sovereign debt) | 353,810 | 133,198 | |||||||
Non-U.S. government-backed corporate | 229,687 | 349,514 | |||||||
Corporate | 1,684,413 | 1,607,233 | |||||||
Agency mortgage-backed | 430,533 | 399,619 | |||||||
Non-agency mortgage-backed | 231,351 | 230,747 | |||||||
Commercial mortgage-backed | 291,284 | 361,645 | |||||||
Asset-backed | 10,745 | 8,511 | |||||||
Total fixed maturity investments trading | $ | 4,751,237 | $ | 4,660,168 | |||||
Included in Accumulated Other Comprehensive Income | |||||||||||||||||||||
September 30, 2013 | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit Other-Than- Temporary Impairments (1) | ||||||||||||||||
Corporate | $ | 2,413 | $ | 322 | $ | (30 | ) | $ | 2,705 | $ | (33 | ) | |||||||||
Agency mortgage-backed | 5,142 | 366 | (17 | ) | 5,491 | — | |||||||||||||||
Non-agency mortgage-backed | 12,315 | 2,504 | (7 | ) | 14,812 | (768 | ) | ||||||||||||||
Commercial mortgage-backed | 10,469 | 1,050 | — | 11,519 | — | ||||||||||||||||
Asset-backed | 3,752 | 251 | — | 4,003 | — | ||||||||||||||||
Total fixed maturity investments available for sale | $ | 34,091 | $ | 4,493 | $ | (54 | ) | $ | 38,530 | $ | (801 | ) | |||||||||
Included in Accumulated Other Comprehensive Income | |||||||||||||||||||||
December 31, 2012 | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit Other-Than- Temporary Impairments (1) | ||||||||||||||||
Corporate | $ | 7,065 | $ | 1,002 | $ | (93 | ) | $ | 7,974 | $ | (85 | ) | |||||||||
Agency mortgage-backed | 8,280 | 632 | — | 8,912 | — | ||||||||||||||||
Non-agency mortgage-backed | 14,613 | 2,989 | (10 | ) | 17,592 | (835 | ) | ||||||||||||||
Commercial mortgage-backed | 37,292 | 7,229 | — | 44,521 | — | ||||||||||||||||
Asset-backed | 4,195 | 248 | — | 4,443 | — | ||||||||||||||||
Total fixed maturity investments available for sale | $ | 71,445 | $ | 12,100 | $ | (103 | ) | $ | 83,442 | $ | (920 | ) | |||||||||
(1) | Represents the non-credit component of other-than-temporary impairments recognized in accumulated other comprehensive income since the adoption of guidance related to the recognition and presentation of other-than-temporary impairments under FASB ASC Topic Financial Instruments – Debt and Equity Securities, during the second quarter of 2009, adjusted for subsequent sales of securities. It does not include the change in fair value subsequent to the impairment measurement date. |
Trading | Available for Sale | Total Fixed Maturity Investments | |||||||||||||||||||||||
September 30, 2013 | Amortized Cost | Fair Value | Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||||||||
Due in less than one year | $ | 166,039 | $ | 166,583 | $ | — | $ | — | $ | 166,039 | $ | 166,583 | |||||||||||||
Due after one through five years | 2,863,742 | 2,876,147 | 1,359 | 1,497 | 2,865,101 | 2,877,644 | |||||||||||||||||||
Due after five through ten years | 633,863 | 629,875 | 647 | 707 | 634,510 | 630,582 | |||||||||||||||||||
Due after ten years | 109,894 | 114,719 | 406 | 501 | 110,300 | 115,220 | |||||||||||||||||||
Mortgage-backed | 938,147 | 953,168 | 27,928 | 31,822 | 966,075 | 984,990 | |||||||||||||||||||
Asset-backed | 10,482 | 10,745 | 3,751 | 4,003 | 14,233 | 14,748 | |||||||||||||||||||
Total | $ | 4,722,167 | $ | 4,751,237 | $ | 34,091 | $ | 38,530 | $ | 4,756,258 | $ | 4,789,767 | |||||||||||||
September 30, 2013 | December 31, 2012 | ||||||||
Consumer | $ | 39,338 | $ | — | |||||
Industrial, utilities and energy | 24,057 | — | |||||||
Financials | 20,828 | 58,186 | |||||||
Health care | 13,443 | — | |||||||
Basic materials | 12,290 | — | |||||||
Communications and technology | 4,030 | — | |||||||
Total | $ | 113,986 | $ | 58,186 | |||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||
Fixed maturity investments | $ | 24,423 | $ | 25,741 | $ | 71,148 | $ | 75,934 | |||||||||
Short term investments | 563 | 236 | 1,318 | 1,006 | |||||||||||||
Equity investments | 706 | 181 | 1,050 | 532 | |||||||||||||
Other investments | |||||||||||||||||
Hedge funds and private equity investments | 14,179 | 10,383 | 31,296 | 28,443 | |||||||||||||
Other | 22,735 | 12,735 | 32,874 | 29,295 | |||||||||||||
Cash and cash equivalents | 47 | 63 | 108 | 143 | |||||||||||||
62,653 | 49,339 | 137,794 | 135,353 | ||||||||||||||
Investment expenses | (2,722 | ) | (3,204 | ) | (8,498 | ) | (8,628 | ) | |||||||||
Net investment income | $ | 59,931 | $ | 46,135 | $ | 129,296 | $ | 126,725 | |||||||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||
Gross realized gains | $ | 8,813 | $ | 19,891 | $ | 60,437 | $ | 75,635 | |||||||||
Gross realized losses | (22,241 | ) | (2,811 | ) | (41,396 | ) | (13,055 | ) | |||||||||
Net realized (losses) gains on fixed maturity investments | (13,428 | ) | 17,080 | 19,041 | 62,580 | ||||||||||||
Net unrealized gains (losses) on fixed maturity investments trading | 33,405 | 56,936 | (85,338 | ) | 83,735 | ||||||||||||
Net realized and unrealized gains (losses) on investments-related derivatives | 3,557 | (955 | ) | 24,488 | (2,390 | ) | |||||||||||
Net realized gains on equity investments trading | 560 | — | 18,195 | — | |||||||||||||
Net unrealized gains (losses) on equity investments trading | 4,378 | 2,236 | (3,174 | ) | 7,057 | ||||||||||||
Net realized and unrealized gains (losses) on investments | $ | 28,472 | $ | 75,297 | $ | (26,788 | ) | $ | 150,982 | ||||||||
Total other-than-temporary impairments | $ | — | $ | — | $ | — | $ | (395 | ) | ||||||||
Portion recognized in other comprehensive income, before taxes | — | — | — | 52 | |||||||||||||
Net other-than-temporary impairments | $ | — | $ | — | $ | — | $ | (343 | ) | ||||||||
Three months ended September 30, 2013 | |||||||||||||
Investments in other ventures | Fixed maturity investments available for sale | Total | |||||||||||
Beginning balance | $ | 218 | $ | 4,691 | $ | 4,909 | |||||||
Other comprehensive (loss) income before reclassifications | (91 | ) | 116 | 25 | |||||||||
Amounts reclassified from accumulated other comprehensive income by statement of operations line item: | |||||||||||||
Realized gains reclassified from accumulated other comprehensive income to net realized and unrealized gains (losses) on investments | — | (368 | ) | (368 | ) | ||||||||
Net current-period other comprehensive loss | (91 | ) | (252 | ) | (343 | ) | |||||||
Ending balance | $ | 127 | $ | 4,439 | $ | 4,566 | |||||||
Nine months ended September 30, 2013 | |||||||||||||
Investments in other ventures | Fixed maturity investments available for sale | Total | |||||||||||
Beginning balance | $ | 1,625 | $ | 11,997 | $ | 13,622 | |||||||
Other comprehensive loss before reclassifications | (1,498 | ) | (10 | ) | (1,508 | ) | |||||||
Amounts reclassified from accumulated other comprehensive income by statement of operations line item: | |||||||||||||
Realized gains reclassified from accumulated other comprehensive income to net realized and unrealized gains (losses) on investments | — | (7,548 | ) | (7,548 | ) | ||||||||
Net current-period other comprehensive loss | (1,498 | ) | (7,558 | ) | (9,056 | ) | |||||||
Ending balance | $ | 127 | $ | 4,439 | $ | 4,566 | |||||||
Less than 12 Months | 12 Months or Greater | Total | |||||||||||||||||||||||
At September 30, 2013 | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||||||||
Corporate | $ | 297 | $ | (22 | ) | $ | 41 | $ | (8 | ) | $ | 338 | $ | (30 | ) | ||||||||||
Agency mortgage-backed | 754 | (17 | ) | — | — | 754 | (17 | ) | |||||||||||||||||
Non-agency mortgage-backed | — | — | 94 | (7 | ) | 94 | (7 | ) | |||||||||||||||||
Total | $ | 1,051 | $ | (39 | ) | $ | 135 | $ | (15 | ) | $ | 1,186 | $ | (54 | ) | ||||||||||
Less than 12 Months | 12 Months or Greater | Total | |||||||||||||||||||||||
At December 31, 2012 | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||||||||
Corporate | $ | 598 | $ | (30 | ) | $ | 440 | $ | (63 | ) | $ | 1,038 | $ | (93 | ) | ||||||||||
Non-agency mortgage-backed | — | — | 101 | (10 | ) | 101 | (10 | ) | |||||||||||||||||
Total | $ | 598 | $ | (30 | ) | $ | 541 | $ | (73 | ) | $ | 1,139 | $ | (103 | ) | ||||||||||
Three months ended September 30, | |||||||||
2013 | 2012 | ||||||||
Beginning balance | $ | 791 | $ | 1,404 | |||||
Additions: | |||||||||
Amount related to credit loss for which an other-than-temporary impairment was not previously recognized | — | — | |||||||
Amount related to credit loss for which an other-than-temporary impairment was previously recognized | — | — | |||||||
Reductions: | |||||||||
Securities sold during the period | (38 | ) | (546 | ) | |||||
Securities for which the amount previously recognized in other comprehensive income was recognized in earnings, because the Company intends to sell the security or is more likely than not the Company will be required to sell the security | — | — | |||||||
Increases in cash flows expected to be collected that are recognized over the remaining life of the security | — | — | |||||||
Ending balance | $ | 753 | $ | 858 | |||||
Nine months ended September 30, | |||||||||
2013 | 2012 | ||||||||
Beginning balance | $ | 838 | $ | 2,370 | |||||
Additions: | |||||||||
Amount related to credit loss for which an other-than-temporary impairment was not previously recognized | — | 8 | |||||||
Amount related to credit loss for which an other-than-temporary impairment was previously recognized | — | 110 | |||||||
Reductions: | |||||||||
Securities sold during the period | (85 | ) | (1,630 | ) | |||||
Securities for which the amount previously recognized in other comprehensive income was recognized in earnings, because the Company intends to sell the security or is more likely than not the Company will be required to sell the security | — | — | |||||||
Increases in cash flows expected to be collected that are recognized over the remaining life of the security | — | — | |||||||
Ending balance | $ | 753 | $ | 858 | |||||
• | Fair values determined by Level 1 inputs utilize unadjusted quoted prices obtained from active markets for identical assets or liabilities for which the Company has access. The fair value is determined by multiplying the quoted price by the quantity held by the Company; |
• | Fair values determined by Level 2 inputs utilize inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets and liabilities in active markets, and inputs other than quoted prices that are observable for the asset or liability, such as interest rates and yield curves that are observable at commonly quoted intervals, broker quotes and certain pricing indices; and |
• | Level 3 inputs are based all or in part on significant unobservable inputs for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. In these cases, significant management assumptions can be used to establish management's best estimate of the assumptions used by other market participants in determining the fair value of the asset or liability. |
At September 30, 2013 | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
Fixed maturity investments | |||||||||||||||||
U.S. treasuries | $ | 1,322,367 | $ | 1,322,367 | $ | — | $ | — | |||||||||
Agencies | 197,047 | — | 197,047 | — | |||||||||||||
Non-U.S. government (Sovereign debt) | 353,810 | — | 353,810 | — | |||||||||||||
Non-U.S. government-backed corporate | 229,687 | — | 229,687 | — | |||||||||||||
Corporate | 1,687,118 | — | 1,661,748 | 25,370 | |||||||||||||
Agency mortgage-backed | 436,024 | — | 436,024 | — | |||||||||||||
Non-agency mortgage-backed | 246,163 | — | 246,163 | — | |||||||||||||
Commercial mortgage-backed | 302,803 | — | 302,803 | — | |||||||||||||
Asset-backed | 14,748 | — | 14,748 | — | |||||||||||||
Total fixed maturity investments | 4,789,767 | 1,322,367 | 3,442,030 | 25,370 | |||||||||||||
Short term investments | 925,329 | — | 925,329 | — | |||||||||||||
Equity investments trading | 113,986 | 113,986 | — | — | |||||||||||||
Other investments | |||||||||||||||||
Private equity partnerships | 327,245 | — | — | 327,245 | |||||||||||||
Senior secured bank loan funds | 19,395 | — | — | 19,395 | |||||||||||||
Catastrophe bonds | 102,141 | — | 102,141 | — | |||||||||||||
Hedge funds | 4,022 | — | — | 4,022 | |||||||||||||
Miscellaneous other investment | 47,967 | — | — | 47,967 | |||||||||||||
Total other investments | 500,770 | — | 102,141 | 398,629 | |||||||||||||
Other assets and (liabilities) | |||||||||||||||||
Derivatives (1) | 3,159 | 127 | 3,314 | (282 | ) | ||||||||||||
Other | (8,801 | ) | — | (8,801 | ) | — | |||||||||||
Total other assets and (liabilities) | (5,642 | ) | 127 | (5,487 | ) | (282 | ) | ||||||||||
$ | 6,324,210 | $ | 1,436,480 | $ | 4,464,013 | $ | 423,717 | ||||||||||
December 31, 2012 | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
Fixed maturity investments | |||||||||||||||||
U.S. treasuries | $ | 1,254,547 | $ | 1,254,547 | $ | — | $ | — | |||||||||
Agencies | 315,154 | — | 315,154 | — | |||||||||||||
Non-U.S. government (Sovereign debt) | 133,198 | — | 133,198 | — | |||||||||||||
Non-U.S. government-backed corporate | 349,514 | — | 349,514 | — | |||||||||||||
Corporate | 1,615,207 | — | 1,587,415 |